Shineco Targets China’s Aging Population With $20 Million Investment

Eyeing China’s lucrative market for age-related conditions, Shineco Inc. is investing in Beijing Oriental Meitong Technology Co. Ltd. (Meitong Technology), shelling out $20 million for 80% of Meitong Technology’s shares.

Shineco executives claim the equity acquisition will broaden the company’s core competencies and result in operating synergies that will enhance its value proposition.
 
Meitong Technology is a durable medical equipment company that provides a variety of shared products to hospitals, healthcare facilities, and patients in their homes. Its intelligent management system enables the firm to coordinate the supply and demand of its shared medical products, including wheelchairs, hospital beds, and power banks, all of which can be customized to a customer’s needs. Meitong Technology maintains business relationships with more than 800 hospitals in China and has more than 10,000 equipment units in use, serving over 12 million patients. Meitong Technology’s annual cash flow is nearly RMB 600 million.

“We are pleased to make this strategic investment since we believe that as China’s elderly population continues to grow, there are excellent growth opportunities for established companies such as Meitong Technology, and we are keen to participate in such growth,” Shineco CEO Jennifer Zhan said. “Also, we believe there will be synergies that will benefit both of our companies and facilitate the expansion of Shineco’s market share in several key markets. We look forward to working with Meitong Technology to see our value proposition become further realized in the market.”
 
The acquisition of 80% of Meitong Technology’s equity is in line with Shineco’s long-term strategy to grow its cash flow, expand its business, and increase its corporate valuation. As part of its growth plan, Meitong Technology plans to enter the nursing, home medical, and funeral equipment and medical supply rental market. In so doing, it intends to achieve a brand matrix competitive advantage with a more diversified product line that includes more products and services available for patients. At the same time, Meitong Technology expects to further consolidate its domestic market share and increase the number of Chinese hospital customers from 800 to 1,500 within three years. In addition, with the resources of Shineco, Meitong Technology expects to enhance the share of its sales in the international medical institutions market and increase the proportion of overseas sales by no less than 20% within three years.
 
As both Shineco and Meitong Technology possess a large amount of data on the needs of the elderly and physically challenged people, the two companies plan to jointly utilize such data for the purpose of the accurate market analysis and product development, providing one-stop solutions in the areas of medical devices, healthy meals, rehabilitation care, etc., so as to better satisfy the market demand and enhance customer loyalty and satisfaction. Further, with Meitong Technology’s extensive domestic channel resources, Shineco will have the opportunity to accelerate its expansion of the domestic and international markets and increase the market penetration and market share of its products.
 
According to the investment letter of intent, Meitong Technology’s management team is entitled to a cash reward up to $200,000 if certain net income growth benchmarks are met between 2025 and 2027 and at least two new technology patents are registered.
 
Shineco Inc. provides high-quality health and medical products and services. Operating through subsidiaries, the company has researched and developed 33 vitro diagnostic reagents and related medical devices to date.